Nouvelles technologies au service de la pathologie rénale : transcriptomique sur tissu fixé et inclus en paraffine
Authors:
- 1 April 2021
- journal article
- review article
- Published by JLE in Nephrologie & Therapeutique
- Vol. 17, S54-S59
Abstract
The development of new high-throughput technologies in genomics and then in transcriptomics has modified clinical approach in nephrology. At the interface between high-throughput technologies (microarray, new generation sequencing «NGS») and few mRNA analysis (reverse transcriptase quantitative PCR [RT-qPCR]), the nCounter® of NanoString® offers a new and complementary approach. Capable of analyzing formalin-fixed paraffin-embedded samples, this technology is a credible candidate for implanting transcriptomics in clinical routine.Keywords
Funding Information
- Agence Nationale de la Recherche
This publication has 40 references indexed in Scilit:
- Acute Pyelonephritis in Renal Allografts–A New Role for MicroRNAs?Transplantation, 2014
- Revolution of nephrology research by deep sequencing: ChIP-seq and RNA-seqKidney International, 2014
- Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approachKidney International, 2013
- Digital Multiplexed Gene Expression Analysis Using the NanoString nCounter SystemCurrent Protocols in Molecular Biology, 2011
- RNA-Seq: a revolutionary tool for transcriptomicsNature Reviews Genetics, 2009
- Direct multiplexed measurement of gene expression with color-coded probe pairsNature Biotechnology, 2008
- Diabetic NephropathyJournal of the American Society of Nephrology, 2006
- Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathyKidney International, 2004
- A panoramic view of gene expression in the human kidneyProceedings of the National Academy of Sciences, 2003
- Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA MicroarrayScience, 1995